Xoma | XOMA - Należności Handlowe





Należności Handlowe Zmiana Data
AbbVie USD 12.59B 180M 2025-12
Agenus USD 22.44M 1.14M 2025-12
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Ardelyx USD 71.85M 4.76M 2025-12
aTyr Pharma USD 296.74M 295.7M 2025-12
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Celldex Therapeutics USD 230K 1.78M 2026-03
Curis USD 2.55M 400K 2024-06
Eli Lilly USD 21.18B 1.02B 2026-03
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Incyte USD 1.05B 27.09M 2026-03
MacroGenics USD 13.37M 55.86M 2025-12
Novartis USD 9.6B 2.69B 2026-03
Novartis USD 12.29B 3.3B 2025-12
Pfizer USD 16.17B 332M 2026-03
Prothena USD 5.16M 0 2023-12
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Xoma USD 14.78M 4.96M 2024-06